Clinical Trial Update: Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma

View source ↗

Summary

A clinical trial investigating multi-omics molecular characteristics and immunophenotyping of signet ring cell carcinoma of the lung, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Signet-ring Cell Carcinoma of the Lung

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Signet Ring Cell Carcinoma of the Lung | Status: RECRUITING